Showing 2644 results
- Media Release /Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five yearsCommitment includes USD…
- Featured News /
COVID-19 is disrupting Africa’s health services – potentially undermining decades of progress on child health.
- Media Release /With unique STAMP mechanism of action, Scemblix could provide a new option for patients in Europe with chronic myeloid leukemia (CML) who have suffered intolerance or inadequate response with at…
- Media Release /New data from the Phase 3 ASCLEPIOS I/II trials and ALITHIOS open-label extension show that after four years nearly 8 out of 10 of people with relapsing multiple sclerosis (RMS) treated continuously…
- Media Release /Approvals based on data from the JUNIPERA trial, showing that Cosentyx® (secukinumab) reduced the risk of flare and disease activity compared to placebo over 2 years in pediatric patients1 with…
- Story /
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
- Media Library /
- Media Library /
- Story /
Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.
- Media Library /
Pagination
- ‹ Previous page
- 1
- …
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- …
- 265
- › Next page